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Patients who survive either ventricular fibrillation or sustained ventricular tachycardia carry a 
high risk of further episodes, which could be fatal. Anti-arrhythmic drugs were the standard 
treatment  for  patients  with  malignant  ventricular  arrhythmias,  but  despite  using  the  best 
appropriate  medical  treatment,  arrhythmia  recurrence rates  remain  high at  40-50% at  five 
years.  Implantable  cardioverter  defibrillators  (ICD)  are  effective  at  treating  ventricular 
arrhythmias  and  there  has  been  clear  evidence  that  they  reduce  mortality.  Cardiac 
resynchronization therapy (CRT) improves symptoms and reduces morbidity and mortality in 
patients with advanced heart failure. In addition, many patients have indications for combined 
ICD  and  CRT  therapy.                                           
While the number of ICD/CRT implantations in the developed world has increased, device 
utilization rates are less in low- and middle-income countries, despite having higher incidence 
of risk factors for sudden cardiac death and heart failure. The primary obstacle to the growth 
of this therapy in developing nations is its cost - ranging from $8000 to $16,000 depending on 
the model and the features available. Due to its cost, this therapy is currently accessible only 
to  the  affluent  in  developing  countries,  whereas  the  subset  of  patients  who  requires  this 
therapy is increasing rapidly. According to available data, only a few hundreds of patients in 
India which has a population of over 120 million receive ICD implants every year, whereas in 
developed countries with much smaller population the number is at least in thousands.       
In  this  context,  devices  donated  for  use  by  charitable  organizations,  industry  or  devices 
harvested by physicians/industry for reuse, becomes extremely important to patients in low- 
and  middle-income  countries.  Reuse  of  devices  poses  risks  such  as  infection,  device 
malfunction and premature battery depletion. But, recently published studies have shown that 
there is no increase in morbidity or mortality associated with device reuse, if implanted with 
good technique and proper sterile precautions. However, there is no proper data or registry 
available regarding the availability of devices with potential for reuse in the developing or 
even  in  the  developed  world.                                            
The HRS guidelines recommend that physicians seek patients' consent for post-mortem device 
retrieval while they are alive. In routine practice, informed consent for device implants rarely 
includes  a  discussion  regarding  post-mortem  handling  of  devices. A  survey  of  patient 
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preferences showed that 87% of patients did not know how devices were handled after their 
death despite the fact that majority were willing to have their devices retrieved for reuse [1].  
Moreover,  patient  preferences  for  post-mortem  handling  affect  health  policies  of  various 
governing  bodies.                                       
In an interesting study published in this issue, Iyer IR and Mackall J tried to unravel veterans' 
preferences regarding post-mortem handling of devices and also to create some data on reuse 
potential of these expensive devices [2]. In this survey, 44.6% of patients wished to donate 
their devices for post mortem reuse as their first choice and 79% chose this among their top 
three options.The analysis  of database showed that  25.6% of all  devices  implanted in the 
deceased cohort had potentially useful remaining battery life.                                 
This is an important study considering that data regarding reuse or reuse potential of these 
expensive  life  saving  devices  are  so  scarce  and  its  implications  especially  in  developing 
countries are many. Major limitations of this study are small sample size and retrospective 
nature for assessing reuse potential of devices. Devices and battery technology analyzed in 
this study are different from currently used devices; recent generation devices show longer 
battery  life  and therefore  may offer  greater  reuse potential.  A larger  study utilizing  large 
datasets maintained by device manufacturers and multiple centers may give a better estimate 
of number of devices with significant reuse potential in order to formulate a health policy on 
this  rather  important  issue.                                        
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